It’s the battle of the sectors between profit taking in healthcare and buying in the oil patch.
There is no up in Nasdaq without healthcare.
With IBB running out all the longs under it’s 200DMA @ 347, I only have
6 names out of 100 I follow in healthcare and Biotech in the green.
We’re currently into some weekly mvg avg support in IBB. It will need to sustain and close under 337 for more downside which would target 325-8 as next support.
It will be a late day game to see who wins.
Spy’s under 195.50 will be negative late.
